DRIO 0.92 (-11.54%)
US23725P2092Medical Diagnostics & ResearchDiagnostics & Research

DarioHealth (DRIO) Competitor Comparison

We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.

Performance 3 years - DRIO ranking 54 / 58

These are the competitors of DarioHealth in the industry Diagnostics & Research ranked by performance 3 years
1. Lantheus Holdings LNTH
269.8
2. Meridian Bioscience VIVO
246.63
3. Medpace Holdings MEDP
114.63
4. RadNet RDNT
50.38
5. Heska HSKA
41.31
6. Icon ICLR
29.16
7. Trinity Biotech TRIB
24.77
8. PerkinElmer PKI
21.19
9. Ortho Clinical Diagnostics Holdings OCDX
13.74
10. Thermo Fisher Scientific TMO
13.58
11. Quest Diagnostics DGX
5.66
12. Danaher DHR
4.35
13. IQVIA Holdings IQV
-2.68
14. Mettler-Toledo MTD
-2.95
15. Laboratory Corp of America Holdings LH
-7.45
16. Agilent Technologies A
-9.74
17. Qiagen QGEN
-11.54
18. Waters WAT
-11.57
19. Natera NTRA
-13.65
20. Myriad Genetics MYGN
-16.43
21. Syneos Health SYNH
-19.01
22. Olink Holding OLK
-22.2
23. Anixa Biosciences ANIX
-25.51
24. Sera Prognostics SERA
-27.5
25. IDEXX Laboratories IDXX
-31.83
26. Charles River Laboratories CRL
-42.84
27. DexCom DXCM
-44.08
28. Sotera Health SHC
-44.55
29. Exact Sciences EXAS
-46.39
30. National Research NRC
-53.08
31. Bioventus BVS
-57.37
32. Neogen NEOG
-61.97
33. NeoGenomics NEO
-62.95
34. Twist Bioscience TWST
-65.28
35. Enzo Biochem ENZ
-66.67
36. Global Cord Blood CO
-67.25
37. Guardant Health GH
-71.88
38. Psychemedics PMD
-72.41
39. CareDx CDNA
-72.89
40. Fulgent Genetics FLGT
-73.02
41. MaxCyte MXCT
-73.35
42. Illumina ILMN
-76.37
43. MDxHealth MDXH
-78.6
44. bioAffinity Technologies BIAF
-79.4
45. Biodesix BDSX
-82.73
46. Personalis PSNL
-82.95
47. Exagen XGN
-83.1
48. Interpace Biosciences IDXG
-85.16
49. Neuronetics STIM
-86.9
50. Organovo Holdings ONVO
-89.19
51. Co-Diagnostics CODX
-89.24
52. Precipio PRPO
-91.85
53. Inotiv NOTV
-93.69
54. DarioHealth DRIO
-93.77
55. Pacific Biosciences of California PACB
-94.82
56. SeqLL SQL
-95.22
57. Prenetics Global PRE
-95.28
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.